The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ... Jan 13
The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ... Nov 23
The FDA granted evinacumab breakthrough therapy designation in 2017 for the treatment of hypercholesterolemia in patients with HoFH... Aug 13
-Advertisements-